Trade Mark Journal No.2026/043 23 October 2026

WO0000001826055 (5)

Office of origin: Switzerland

Date of International Registration:9 October 2024
Date of designation in the UK: 17 September 2026
Image for mark 1826055_TIF RELINIFY

Class 5
Pharmaceutical preparations.

Takeda Pharmaceuticals U.S.A., Inc.

Representative: HGF Limited, 4th Floor, 1 City Square Leeds LS1 2ES UNITED KINGDOM